In late June, the FDA approved PHESGO™ (pertuzumab/ trastuzumab/ hyaluronidase-zzxf), a treatment that can be injected under the skin, to treat metastatic and early-stage HER2 positive breast cancer. Because it is given as an injection, PHESGO™ can be given by a healthcare professional in your home, and takes less time than an infusion.
July 2020Read More
The treatment landscape for HER2 positive metastatic breast cancer has been rapidly evolving. Since February, the FDA has approved three new drugs to treat it:...
New To Clinical Trials?
The idea of finding and entering a clinical trial can seem daunting. Here’s a Clinical Trials Primer to get you started.
COVID-19 & Breast Cancer
Search Our Site
SEARCH OUR SITE
for past articles or specific information.